Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines
-
M. Keith Howard
Abstract
The rapid spread of avian influenza (H5N1) and its transmission to humans has raised the possibility of an imminent pandemic and concerns over the ability of standard influenza vaccine production methods to supply sufficient amounts of an effective vaccine. We report here on a robust and flexible strategy which uses wild-type virus grown in a continuous cell culture (Vero) system to produce an inactivated whole virus vaccine. Candidate vaccines based on clade 1 and clade 2 influenza H5N1 strains, produced at a variety of manufacturing scales, were demonstrated to be highly immunogenic in animal models without the need for adjuvant. The vaccines induce cross-neutralising antibodies and are protective in a mouse challenge model not only against the homologous virus but against other H5N1 strains, including those from other clades. These data indicate that cell culture-grown, whole virus vaccines, based on the wild-type virus, allow the rapid high-yield production of a candidate pandemic vaccine.
©2008 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Guest Editorial
- Novel paradigms in vaccine development: from small pox eradication to therapeutic vaccines
- Highlight: 3rd Semmering Conference 2007
- Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine
- Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors
- Novel strategies to identify biomarkers in tuberculosis
- Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection
- Lipopolysaccharide: a tool and target in enterobacterial vaccine development
- The coming of age of virus-like particle vaccines
- Maintenance of serological memory
- Adjuvant activity of type I interferons
- Japanese encephalitis vaccines – needs, flaws and achievements
- Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals
- Non-regulatory CD8+CD45RO+CD25+ T-lymphocytes may compensate for the loss of antigen-inexperienced CD8+CD45RA+ T-cells in old age
- Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines
- Construction of an encapsulated ESAT-6-based anti-TB DNA vaccine and evaluation of its immunogenic properties
- Review
- RNA switches regulate initiation of translation in bacteria
- Protein Structure and Function
- Inhibition of bacterial oxidases by formamide and analogs
- Modeling of variant copies of subunit D1 in the structure of photosystem II from Thermosynechococcus elongatus
Articles in the same Issue
- Guest Editorial
- Novel paradigms in vaccine development: from small pox eradication to therapeutic vaccines
- Highlight: 3rd Semmering Conference 2007
- Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine
- Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors
- Novel strategies to identify biomarkers in tuberculosis
- Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection
- Lipopolysaccharide: a tool and target in enterobacterial vaccine development
- The coming of age of virus-like particle vaccines
- Maintenance of serological memory
- Adjuvant activity of type I interferons
- Japanese encephalitis vaccines – needs, flaws and achievements
- Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals
- Non-regulatory CD8+CD45RO+CD25+ T-lymphocytes may compensate for the loss of antigen-inexperienced CD8+CD45RA+ T-cells in old age
- Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines
- Construction of an encapsulated ESAT-6-based anti-TB DNA vaccine and evaluation of its immunogenic properties
- Review
- RNA switches regulate initiation of translation in bacteria
- Protein Structure and Function
- Inhibition of bacterial oxidases by formamide and analogs
- Modeling of variant copies of subunit D1 in the structure of photosystem II from Thermosynechococcus elongatus
